Unilife — Q3 FY2013 Earnings Presentation
10 slides from Unilife's earnings presentation, May 10, 2013
Slide 1: Fiscal Year 2013 3rd Quarter Earnings Call
NASDAQ (UNIS) and ASX (UNS) Fiscal Year 2013 3rd Quarter Earnings Call May 9, 2013
Slide 2: Cautionary Note Regarding Forward-Looking Statements
This presentation contains forward looking statements under the safe harbor provisions of the US securities laws. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-lo
Slide 3: CEO Alan Shortall
CEO Alan Shortall NASDAQ (UNIS) and ASX (UNS)
Slide 4: Upcoming Long-Term Unifill Supply Contract
Upcoming Long-Term Unifill Supply Contract Multi-year supply contract with large cap pharmaceutical customerNegotiations complete. All terms agreed. Execution copy routed for signatureExpected to generate revenues immediatelyPress conference in New York being scheduled in next few weeks May 10, 2013
Slide 5: A Turning Point for Unilife
First in a series of agreements announced last month - a 15-year customization and commercial supply contract for EZMixAdditional upcoming agreements across entire product portfolio are close to finalization, expected to generate immediate revenueImportant that sufficient time given to each agreemen
Slide 6: Debt Financing to Minimize Dilution
Debt Financing to Minimize Dilution Prudently managing our cash position in advance of upcoming agreements being announcedNo intention of a secondary stock offering so as to minimize dilution to existing shareholdersAgreed to terms for debt funding program with a major U.S. life science financing fi
Slide 7: Financial Data Overview, Rich Wieland, Chief Financial Officer
Financial Data Overview Rich Wieland Chief Financial Officer
Slide 8: Financial Data
Financial Data 3Q 2013 3Q 2012 Revenues $ 0.7M $ 1.3M Research & development expense $ 5.5M $ 6.7M Selling, general & administrative expense $ 7.3M $ 7.7M Net loss $ 14.1M $ 14.9M Net loss per share - diluted $ 0.17 $ 0.21 Adjusted net loss $ 9.4M $ 10.7M Adjusted net loss per share - diluted $ 0.12
Slide 9: CEO Alan Shortall
CEO Alan Shortall NASDAQ (UNIS) and ASX (UNS)
Slide 10: Questions
Questions May 10, 2013